Xerostomia relacionada à infecção pelo HIV/AIDS: uma revisão crítica
Xerostomia related to HIV infection /AIDS: a critical review
Tinós, Adriana Maria F.; Sales-Peres, Silvia Helena de Carvalho
Resumo
Introdução: A presença de manifestações bucais em indivíduos HIV positivos é bastante comum, sendo que a xerostomia aparece como um dos problemas mais frequentes, podendo levar a uma redução na qualidade de vida dessa população. Objetivo: Este estudo objetivou realizar uma revisão crítica sobre a relação entre xerostomia e a infecção pelo HIV, a fim de despertar a atenção do cirurgião-dentista quanto à importância da atenção odontológica dirigida a esses pacientes. Material e método: Foram incluídos artigos publicados no período entre 2000 e 2009, indexados na base de dados PUBMED. Os descritores utilizados foram HIV e xerostomia, sendo adotados como critérios de exclusão: a ausência dos referidos descritores associados, a não localização do texto completo, os artigos baseados em estudos de caso ou série de casos, e a ausência do resumo na base de dados. Resultado: Com base nos estudos incluídos na revisão, pode-se afirmar que a xerostomia é uma manifestação comum da infecção pelo HIV, predispondo o paciente a vários outros problemas bucais. Dentre os fatores de risco para a sua ocorrência, foram relacionados: as baixas contagens de células T CD4+, a alta carga viral plasmática, o uso de alguns medicamentos e a terapia antirretroviral. Conclusão: A infecção pelo HIV/AIDS pode alterar as glândulas salivares. Além disso, importantes fatores de risco foram considerados para ocorrência de xerostomia: a presença da didanosina e da classe de medicamentos que corresponde aos inibidores de protease na terapia antirretroviral.
Palavras-chave
Abstract
Introduction: The presence of oral manifestations in HIV positive individuals is quite common. Xerostomia appears as one of the most frequent problems and may lead to a reduction in the quality of life of this population. Objective: This study was a critical review of the relationship between xerostomia and HIV infection, to attract the attention of dentists on the importance of dental care to these patients. Material and method: We included articles published between 2000 and 2009, indexed in PUBMED database. The descriptors used were "HIV" and "xerostomia", the exclusion criteria adopted were: the absence of these descriptors associated, non-location of the full-text, articles based on case studies or case series and the absence of the abstract in the database. Result: Based on studies in the review, it can be said that the xerostomia is a common manifestation of HIV infection, predisposing the patient to several other oral problems. Among the risk factors for its occurrence it was reported: low counts of CD4+ T cells, high plasma viral load, the use of some medications and antiretroviral therapy. Conclusion: The HIV/ AIDS can change the salivary glands, and were considered important risk factors for the occurrence of xerostomia the presence of didanosine and the drug class which corresponds to protease inhibitors in antiretroviral therapy.
Keywords
References
1. Cavasin Filho JC, Giovani EM. Xerostomy, dental caries and periodontal disease in HIV+ patients. Braz J Infect Dis. 2009;13(1):13-7. http://dx.doi.org/10.1590/S1413-86702009000100005
2. Ceballos-Salobreña A, Gaitán-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDS. 2000;14(12):627-35. http://dx.doi.org/10.1089/10872910050206540
3. Freed JR, Marcus M, Freed BA, Der-Martirosian C, Maida CA, Younai FS, et al. Oral health findings for HIV-infected adult medical patients from the HIV Cost and Services Utilization Study. J Am Dent Assoc. 2005;136(10):1396-405. http://dx.doi.org/10.14219/jada. archive.2005.0053
4. Wainberg MA, Jeang KT. 25 years of HIV-1 research – progress and perspectives. BMC Medicine. 2008;6:31:1-7.
5. Flint SR, Tappuni A, Leigh J, Schmidt-Westhausen AM, MacPhail L. (B3) Markers of immunodeficiency and mechanisms of HAART therapy on oral lesions. Adv Dent Res. 2006;19(1):146-51. http://dx.doi.org/10.1177/154407370601900126
6. Gileva OS, Sazhina MV, Gileva ES, Efimov AV, Scully C. Spectrum of oral manifestations of HIV/AIDS in the Perm region (Russia) and identification of self-induced ulceronecrotic lingual lesions. Med Oral. 2004;9(3):212-5.
7. Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2006;13(5):143-8.
8. Lin AL, Johnson DA, Stephan KT, Yeh CK. Alteration in salivary function in early HIV infection. J Dent Res. 2003;82(9):719-24. http:// dx.doi.org/10.1177/154405910308200912
9. Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res. 2000;79(7):1502-7. http://dx.doi.org/10.1177/00220345000790071201
10. Expósito-Delgado AJ, Vallejo-Bolaños E, Martos-Cobo EG. Oral manifestations of HIV infection in infants: a review article. Med Oral Patol Oral Cir Bucal. 2004;9(5):415-20.
11. Pinto A, De Rossi SS. Salivary gland disease in pediatric HIV patients: an update. J Dent Child (Chic). 2004;71(1):33-7.
12. Sroussi HY, Epstein JB. Changes in the pattern of oral lesions associated with HIV infection: implications for dentists. J Can Dent Assoc. 2007;73(10):949-52.
13. Narani N, Epstein JB. Classifications of oral lesions in HIV infection. J Clin Periodontol. 2001;28(2):137-45. http://dx.doi.org/10.1034/ j.1600-051x.2001.028002137.x
14. Chou L. [Clinical and research advances in oral AIDS]. Shangai Kou Qiang Yi Xue 2001;10(3):193-5.
15. Johnson NW, Glick M; Mbuguye TN. (A2) Oral health and general health. Adv Dent Res. 2006;19(1):118-21. http://dx.doi. org/10.1177/154407370601900122
16. Kozinetz CA, Carter AB, Simon C, Hicks MJ, Rossmann SN, Flaitz CM, et al. Oral manifestations of pediatric vertical HIV infection. AIDS Patient Care STDS. 2000;14(2):89-94. http://dx.doi.org/10.1089/108729100318028
17. Grando LJ, Yurgel LS, Machado DC, Silva CL, Menezes M, Picolli C. [Oral manifestations, CD4+ T-lymphocytes count and viral load in Brazilian and North-American HIV-infected children]. Pesqui Odontol Bras. 2002;16(1):18-25. http://dx.doi.org/10.1590/S1517- 74912002000100004
18. Tirwomwe JF, Rwenyonyi CM, Muwazi LM, Besigye B, Mboli F. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda. Clin Oral Investig. 2007;11(3):289-92. http://dx.doi.org/10.1007/s00784-007-0118-z
19. Jainkittivong A, Lin AL, Johnson DA, Langlais RP, Yeh CK. Salivary secretion, mucin concentrations and Candida carriage in HIVinfected patients. Oral Dis. 2009;15(3):229-34. http://dx.doi.org/10.1111/j.1601-0825.2009.01514.x
20. Navazesh M, Mulligan R, Barron Y, Redford M, Greenspan D, Alves M, et al. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women’s Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(6):693-8. http://dx.doi.org/10.1067/moe.2003.230
21. Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis. 2006;12(6):537-42. http://dx.doi.org/10.1111/j.1601-0825.2006.01232.x
22. Navazesh M, Mulligan R, Karim R, Mack WJ, Ram S, Seirawan H, et al. Effect of HAART on salivary gland function in the Women’s Interagency HIV Study (WIHS). Oral Dis. 2009;15(1):52-60. http://dx.doi.org/10.1111/j.1601-0825.2008.01456.x
23. Aquino-García SI, Rivas MA, Ceballos-Salobreña A, Acosta-Gio AE, Gaitán-Cepeda LA. Short communication: oral lesions in HIV/ AIDS patients undergoing HAART including efavirenz. AIDS Res Hum Retroviruses 2008;24(6):815-20. http://dx.doi.org/10.1089/ aid.2007.0159
24. Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women’s Interagency HIV Study. Clin Infect Dis. 2004;39(5):717-24. http://dx.doi.org/10.1086/423181
25. Younai FS, Marcus M, Freed JR, Coulter ID, Cunningham W, Der-Martirosian C, et al. Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92(6):629-36. http://dx.doi. org/10.1067/moe.2001.117816
26. Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun. 2001;16(3):275-85. http://dx.doi.org/10.1006/jaut.2000.0488
27. Fox RI, Liu AY. Sjogren’s syndrome in dermatology. Clin Dermatol. 2006;24(5):393-413. http://dx.doi.org/10.1016/j.clindermatol.2006.07.005
28. von Bultzingslowen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl):S57. e1-15.
29. Patel M, Shackleton JA, Coogan MM, Galpin J. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatmentna ive HIV-infected patients. AIDS Patient Care STDS. 2008;22(8):613-8. http://dx.doi.org/10.1089/apc.2007.0160
30. Mulligan R, Seirawan H, Alves ME, Navazesh M, Phelan JA, Greenspan D, et al. Oral health-related quality of life among HIV-infected and at-risk women. Community Dent Oral Epidemiol. 2008;36(6):549-57. http://dx.doi.org/10.1111/j.1600-0528.2008.00443.x
31. Engeland CG, Jang P, Alves M, Marucha PT, Califano J. HIV infection and tooth loss. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(3):321-6. http://dx.doi.org/10.1016/j.tripleo.2007.10.012
32. Eveson JW. Xerostomia. Periodontol 2000. 2008;48:85–91. http://dx.doi.org/10.1111/j.1600-0757.2008.00263.x
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email